Filing Details
- Accession Number:
- 0001722482-23-000023
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-02 20:25:41
- Reporting Period:
- 2023-01-31
- Accepted Time:
- 2023-02-02 20:25:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1722482 | Avantor Inc. | AVTR | Laboratory Analytical Instruments (3826) | 822758923 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1776107 | Gerard Brophy | Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road Radnor PA 19087 | Evp, Biopharma Production | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-01-31 | 38,737 | $0.00 | 128,945 | No | 4 | A | Direct | |
Common Stock | Disposition | 2023-01-31 | 15,221 | $23.90 | 113,724 | No | 4 | F | Direct | |
Common Stock | Disposition | 2023-02-02 | 11,339 | $25.06 | 102,385 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Reflects performance-based restricted stock units previously granted to the Reporting Person, the performance of which was certified on January 31, 2023. Each performance-based restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer.
- Reflects shares of Common Stock withheld to cover the Reporting Person's tax liability in connection with the vesting and settlement of the performance-based restricted stock units described herein.
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.00 to $25.15, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above.